Literature DB >> 29911252

Progress in moyamoya disease.

Shuling Shang1,2,3, Da Zhou1,2, Jingyuan Ya1,2, Sijie Li1,2, Qi Yang1, Yuchuan Ding2,4, Xunming Ji1,2, Ran Meng5,6.   

Abstract

Moyamoya disease is characterized by progressive stenosis or occlusion of the intracranial portion of the internal carotid artery and their proximal branches, resulting in ischemic or hemorrhagic stroke with high rate of disability and even death. So far, available treatment strategies are quite limited, and novel intervention method is being explored. This review encapsulates current advances of moyamoya disease on the aspects of epidemiology, etiology, clinical features, imaging diagnosis and treatment. In addition, we also bring forward our conjecture, which needs to be testified by future research.

Entities:  

Keywords:  Clinical features; Diagnosis; Epidemiology; Moyamoya disease; Treatment

Year:  2018        PMID: 29911252     DOI: 10.1007/s10143-018-0994-5

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  103 in total

1.  High-resolution MR technique can distinguish moyamoya disease from atherosclerotic occlusion.

Authors:  Jeong-Min Kim; Keun-Hwa Jung; Chul-Ho Sohn; Jaeseok Park; Jangsup Moon; Moon Hee Han; Jae-Kyu Roh
Journal:  Neurology       Date:  2013-02-19       Impact factor: 9.910

2.  Delayed posterior circulation insufficiency in pediatric moyamoya disease.

Authors:  Ji Yeoun Lee; Young-Hun Choi; Jung-Eun Cheon; Jin Chul Paeng; Hye Won Ryu; Ki Joong Kim; Ji Hoon Phi; Kyu-Chang Wang; Byung-Kyu Cho; Jong-Hee Chae; Seung-Ki Kim
Journal:  J Neurol       Date:  2014-09-12       Impact factor: 4.849

3.  Epidemiological features of moyamoya disease in Japan.

Authors:  Haruhiko Hoshino; Yoshikane Izawa; Norihiro Suzuki
Journal:  Neurol Med Chir (Tokyo)       Date:  2012       Impact factor: 1.742

4.  Chronic ischemia alters brain microstructural integrity and cognitive performance in adult moyamoya disease.

Authors:  Ken Kazumata; Khin Khin Tha; Hisashi Narita; Ichiro Kusumi; Hideo Shichinohe; Masaki Ito; Naoki Nakayama; Kiyohiro Houkin
Journal:  Stroke       Date:  2014-12-23       Impact factor: 7.914

5.  Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.

Authors:  Xing-ju Liu; Dong Zhang; Shuo Wang; Yuan-li Zhao; Mario Teo; Rong Wang; Yong Cao; Xun Ye; Shuai Kang; Ji-Zong Zhao
Journal:  J Neurosurg       Date:  2014-11-28       Impact factor: 5.115

6.  Clinical assessment of cerebral hemodynamics in Moyamoya disease via multiple inversion time arterial spin labeling and dynamic susceptibility contrast-magnetic resonance imaging: A comparative study.

Authors:  Peng-Gang Qiao; Cong Han; Zhi-Wei Zuo; Yi-Tuo Wang; Josef Pfeuffer; Lian Duan; Tianyi Qian; Gong-Jie Li
Journal:  J Neuroradiol       Date:  2017-02-04       Impact factor: 3.447

7.  Treatment of moyamoya disease by temporal muscle graft 'encephalo-myo-synangiosis'.

Authors:  S Takeuchi; T Tsuchida; K Kobayashi; M Fukuda; R Ishii; R Tanaka; J Ito
Journal:  Childs Brain       Date:  1983

8.  Basic fibroblast growth factor in human saliva: detection and physiological implications.

Authors:  G B van Setten
Journal:  Laryngoscope       Date:  1995-06       Impact factor: 3.325

9.  Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease.

Authors:  J Masuda; J Ogata; C Yutani
Journal:  Stroke       Date:  1993-12       Impact factor: 7.914

10.  High resolution MRI difference between moyamoya disease and intracranial atherosclerosis.

Authors:  Y J Kim; D H Lee; J Y Kwon; D W Kang; D C Suh; J S Kim; S U Kwon
Journal:  Eur J Neurol       Date:  2013-06-21       Impact factor: 6.089

View more
  17 in total

1.  RNF213 gene polymorphism rs9916351 and rs8074015 significantly associated with moyamoya disease in Chinese population.

Authors:  Bin Zhu; Xingju Liu; Xueke Zhen; Xixi Li; Mingfen Wu; Yan Zhang; Zhigang Zhao; Dong Zhang; Jizong Zhao
Journal:  Ann Transl Med       Date:  2020-07

2.  Surgical revascularization vs. conservative treatment for adult hemorrhagic moyamoya disease: analysis of rebleeding in 322 consecutive patients.

Authors:  Shaojie Yu; Nan Zhang; Jian Liu; Changwen Li; Sheng Qian; Yong Xu; Tao Yang; Nan Li; Minghui Zeng; Dongxue Li; Chengyu Xia
Journal:  Neurosurg Rev       Date:  2021-12-03       Impact factor: 3.042

3.  Morning glory disc anomaly associated with moyamoya disease and pituitary stalk duplication.

Authors:  Mohamed M Khodeiry; Viet Q Chau; Anas Yasin; Robert M Starke; Shahnaz Miri; Joshua Pasol
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-24

4.  Impairments in brain perfusion, executive control network, topological characteristics, and neurocognition in adult patients with asymptomatic Moyamoya disease.

Authors:  Shihao He; Ziqi Liu; Yanchang Wei; Ran Duan; Zongsheng Xu; Cai Zhang; Li Yuan; Tian Li; Ning Ma; Xin Lou; Xiaoyuan Liu; Rong Wang
Journal:  BMC Neurosci       Date:  2021-05-12       Impact factor: 3.288

Review 5.  Pathological Circulating Factors in Moyamoya Disease.

Authors:  Yao-Ching Fang; Ling-Fei Wei; Chaur-Jong Hu; Yong-Kwang Tu
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

6.  Construction and Comprehensive Analysis of Dysregulated Long Noncoding RNA-Associated Competing Endogenous RNA Network in Moyamoya Disease.

Authors:  Xuefeng Gu; Dongyang Jiang; Yue Yang; Peng Zhang; Guoqing Wan; Wangxian Gu; Junfeng Shi; Liying Jiang; Bing Chen; Yanjun Zheng; Dingsheng Liu; Sufen Guo; Changlian Lu
Journal:  Comput Math Methods Med       Date:  2020-06-13       Impact factor: 2.238

7.  Remote ischemic conditioning for the treatment of ischemic moyamoya disease.

Authors:  Jia-Yue Ding; Shu-Ling Shang; Zhi-Shan Sun; Karam Asmaro; Wei-Li Li; Qi Yang; Yu-Chuan Ding; Xun-Ming Ji; Ran Meng
Journal:  CNS Neurosci Ther       Date:  2019-12-08       Impact factor: 5.243

8.  High-resolution combined arterial spin labeling MR for identifying cerebral arterial stenosis induced by moyamoya disease or atherosclerosis.

Authors:  Jingyuan Ya; Da Zhou; Jiayue Ding; Yuchuan Ding; Xunming Ji; Qi Yang; Ran Meng
Journal:  Ann Transl Med       Date:  2020-02

9.  Corticostriatal Hypermetabolism in Moyamoya Disease-Induced Hemichorea: Two Case Reports and a Literature Review.

Authors:  Wen-Biao Xian; Xiang-Song Zhang; Xin-Chong Shi; Gan-Hua Luo; Chang Yi; Zhong Pei
Journal:  Front Neurol       Date:  2021-06-24       Impact factor: 4.003

10.  Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study.

Authors:  Yixin Sun; Guoyu Zhou; Jingnan Feng; Lu Chen; Guozhen Liu; Jinxi Wang; Qingliang Wang; Junyou Yu; Xiwang Yang; Zheng Yang; Pei Gao; Shengfeng Wang; Siyan Zhan
Journal:  Stroke Vasc Neurol       Date:  2021-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.